Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: Multicentre, population based, observational study
BMJ Oct 22, 2017
Jun M, et al. - The safety of direct oral anticoagulant (DOAC) use compared with warfarin use for the treatment of venous thromboembolism was ascertained in this study. In this analysis of adults with incident venous thromboembolism, treatment with DOACs, compared with warfarin, was not related to an increased risk of major bleeding or all-cause mortality in the initial 3 months of treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
